Lonza Microreactors & Continuous Flow Services
Microreactor technology is based on continuous plug flow reactors. Lonza has designed microreactors that allow processes to be developed in the lab and easily transferred to the production environment.
Microreactor technology is based on continuous plug flow reactors. Lonza has designed microreactors that allow processes to be developed in the lab and easily transferred to the production environment. Batch processes have been replaced by continuous operating modules that provide automated process control and reduce operating expenses.
Lonza MicroReactors Product Features:
- Compact, modular, robust (over 100 bar)
- Hastelloy for chemical resistance, aluminum for heat exchange
- Consistent scale-up from laboratory to large-scale manufacturing totally avoiding vparallelization / numbering-up strategies
- Has been tested for several Lonza products up to ton scale
Lonza Continuous Flow Services Offer:
- More than 100 year experiences on flow processes
- Highly flexible and versatile flow laboratories
- In-house proven and multi-purpose flow manufacturing capabilities
- Know-how & solutions with key flow issues including plugging and long term stability
For further detailed information about Lonza’s MicroReactors or other products and services, visit us at www.lonza.com, or contact us at microreactor@lonza.com.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
